AYSE MINDIKOGLU to Middle Aged
This is a "connection" page, showing publications AYSE MINDIKOGLU has written about Middle Aged.
Connection Strength
0.576
-
Intermittent fasting from dawn to sunset for four consecutive weeks induces anticancer serum proteome response and improves metabolic syndrome. Sci Rep. 2020 10 27; 10(1):18341.
Score: 0.045
-
Cystatin C Is a Gender-Neutral Glomerular Filtration Rate Biomarker in Patients with Cirrhosis. Dig Dis Sci. 2018 03; 63(3):665-675.
Score: 0.037
-
Unique metabolomic signature associated with hepatorenal dysfunction and mortality in cirrhosis. Transl Res. 2018 05; 195:25-47.
Score: 0.037
-
Prevalence, Severity, and Impact of Renal Dysfunction in Acute Liver Failure on the US Liver Transplant Waiting List. Dig Dis Sci. 2016 Jan; 61(1):309-16.
Score: 0.031
-
Pharmacokinetics and Tolerability of Intravenous Sildenafil in Two Subjects with Child-Turcotte-Pugh Class C Cirrhosis and Renal Dysfunction. Dig Dis Sci. 2015 Nov; 60(11):3491-4.
Score: 0.031
-
Estimation of Glomerular Filtration Rate in Patients With Cirrhosis by Using New and Conventional Filtration Markers and?Dimethylarginines. Clin Gastroenterol Hepatol. 2016 Apr; 14(4):624-632.e2.
Score: 0.031
-
A pilot study to evaluate renal hemodynamics in cirrhosis by simultaneous glomerular filtration rate, renal plasma flow, renal resistive indices and biomarkers measurements. Am J Nephrol. 2014; 39(6):543-52.
Score: 0.029
-
Outcomes of living versus deceased donor liver transplantation for acute liver failure in the United States. Transplant Proc. 2014 Jan-Feb; 46(1):219-24.
Score: 0.028
-
Performance of chronic kidney disease epidemiology collaboration creatinine-cystatin C equation for estimating kidney function in cirrhosis. Hepatology. 2014 Apr; 59(4):1532-42.
Score: 0.027
-
Comparison of seven liver allocation models with respect to lives saved among patients on the liver transplant waiting list. Transpl Int. 2012 Apr; 25(4):409-15.
Score: 0.024
-
Simultaneous liver-kidney versus liver transplantation alone in patients with end-stage liver disease and kidney dysfunction not on dialysis. Transplant Proc. 2011 Sep; 43(7):2669-77.
Score: 0.024
-
Gender disparity in liver transplant waiting-list mortality: the importance of kidney function. Liver Transpl. 2010 Oct; 16(10):1147-57.
Score: 0.022
-
Outcome of liver transplantation for drug-induced acute liver failure in the United States: analysis of the United Network for Organ Sharing database. Liver Transpl. 2009 Jul; 15(7):719-29.
Score: 0.020
-
Hepatitis C in the elderly: epidemiology, natural history, and treatment. Clin Gastroenterol Hepatol. 2009 Feb; 7(2):128-34; quiz 124.
Score: 0.020
-
Impact of human immunodeficiency virus on survival after liver transplantation: analysis of United Network for Organ Sharing database. Transplantation. 2008 Feb 15; 85(3):359-68.
Score: 0.019
-
The impact of nonalcoholic fatty liver disease and the metabolic syndrome on progression of fibrosis in patients with recurrent HCV after liver transplantation. Transplant Proc. 2006 Jun; 38(5):1440-4.
Score: 0.017
-
Epithelioid hemangioendothelioma of the liver. Clin Gastroenterol Hepatol. 2005 Jul; 3(7):xxxii.
Score: 0.016
-
Post-transplant IVC occlusion and thrombosis treated with tPA, heparin, and sharp recanalization. J Gastroenterol. 2005 Mar; 40(3):302-5.
Score: 0.015
-
Prochlorperazine-induced cholestasis in a patient with alpha-1 antitrypsin deficiency. Hepatogastroenterology. 2003 Sep-Oct; 50(53):1338-40.
Score: 0.014
-
Splenic embolization in a Jehovah's Witness: role of recombinant human factor VIIa. Hepatogastroenterology. 2003 Sep-Oct; 50(53):1697-9.
Score: 0.014
-
The decreasing predictive power of MELD in an era of changing etiology of liver disease. Am J Transplant. 2019 12; 19(12):3299-3307.
Score: 0.010
-
No Gains in Long-term Survival After Liver Transplantation Over the Past Three Decades. Ann Surg. 2019 01; 269(1):20-27.
Score: 0.010
-
Predicting Liver Allograft Discard: The Discard Risk Index. Transplantation. 2018 09; 102(9):1520-1529.
Score: 0.010
-
Liver transplant length of stay (LOS) index: A novel predictive score for hospital length of stay following liver transplantation. Clin Transplant. 2017 Dec; 31(12).
Score: 0.009
-
Long-term influence of chemotherapy on steatosis-associated advanced hepatic fibrosis. Med Oncol. 2014 Jun; 31(6):971.
Score: 0.007
-
End-stage renal disease and African American race are independent predictors of mild liver fibrosis in patients with chronic hepatitis C infection. J Viral Hepat. 2012 May; 19(5):371-6.
Score: 0.006
-
Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease. Liver Transpl. 2009 Dec; 15(12):1814-20.
Score: 0.005
-
Recombinant human factor VIIa-induced alterations in tissue factor and thrombomodulin in patients with advanced liver cirrhosis. J Gastroenterol Hepatol. 2005 Jun; 20(6):882-9.
Score: 0.004
-
Platelet sparing effect of COX II inhibition used with pegylated interferon alfa-2a for the treatment of chronic hepatitis C: a short term pilot study. Cytokine. 2004 Sep 21; 27(6):159-65.
Score: 0.004
-
Cardiovascular problems in cirrhotic patients. Turk J Gastroenterol. 2004 Sep; 15(3):126-32.
Score: 0.004
-
Modulation of endothelial cell inflammatory integrins and stress markers with rh-factor VIIa in patients with advanced chronic hepatitis C. J Viral Hepat. 2003 Jul; 10(4):310-7.
Score: 0.003
-
Use of activated recombinant human factor VII (rhFVIIa) for colonic polypectomies in patients with cirrhosis and coagulopathy. Dig Dis Sci. 2003 Jul; 48(7):1414-24.
Score: 0.003